PDE-5 inhibitors dietary supplements orbitrap adulteration high resolution tandem mass spectrometry a b s t r a c t Popularity of natural-based preparations supporting the sexual potency significantly increased in recent years, which also led to the increase of illegal use of phosphodiesterase type 5 inhibitor (PDE-5) in sexual performance enhancement products. In this study, a rapid U-HPLC-HRMS/MS method has been developed to simultaneously determine 59 PDE-5 inhibitors and their analogues.
Introduction
During the recent years, consumersínterest to support their health through the use of purely naturally-based dietary supplements continues to increase. There is a big variety of products at the market, promising treatment of various types of health problems, and usually sold at very high prices. The economic matters are mostly the reason why these preparations often become a subject of fraud. Frequently occurring type of adulteration practices is addition of synthetic drugs or their analogues to the naturallybased product, to ensure or strengthen the specific pharmacological effect [1] .
cations are with antihypertensives, antidepresives, sedatives and anxiolytics, which can result in stroke and heart attack [8] .
Despite their large consumption by people, there is still lack of proper analytical methods usable for sensitive chemical analysis of these dietary supplements. As concerns the target analysis of PDE-5 inhibitors and their analogues, the main problem is usually the complexity of matrices which are mostly based on mixtures of herbs or herb extracts, containing an abundant number of potentially co-eluting matrix compounds.
When developing a method of target PDE-5 inhibitors analysis, proper extraction procedure, but also a final separation and detection are important, especially in case of very complex matrices. For solid samples, as tablets or capsules with powdered extract, extraction by shaking with aqueous mixtures of methanol or acetonitrile, sometimes supported by sonication, are usually used [1, [8] [9] [10] [11] . For liquid dietary supplements preparations, as syrups or drops, the dilute-and-shoot approach is usually realized [9] .
The best approach how to sensitively reveal the undeclared PDE-5 inhibitors is mass spectrometry [10] , usually preceded with ultra-performance liquid chromatography (U-HPLC) [3, 11] . Nevertheless, as comprehensively reviewed by Vaclavik et al. 2014 , also the direct analysis without chromatographic separation could be a good alternative [3] . Despite the fact that some PDE-5 inhibitors could be detected also by UV or FLD [12] , the MS usually provides better sensitivity, selectivity and universality, enabling determination of multiple adulterants and their analogues in one chromatographic run [3, 9, 13] . The multi-detecting LC-MS methods published over the last ten years have been reviewed and described in detail in the following paragraph. The details about the methods performance are also summarized in Table 1 . Ren et al. (2012) developed a method for simultaneous screening and quantitation of 18 illegal adulterants in methanolic extracts of herbal-based foods and medicines supporting male sexual potency, by ultra-fast liquid chromatography coupled with electrospray ionization triple quadrupole tandem MS. The validated method was then successfully applied to analyze 16 samples, nine of which were confirmed to contain illegal adulterants at the therapeutic dosages [14] . One year later, an LC-MS-based method for simultaneous determination of 38 PDE-5 inhibitors in illicit sexual performance enhancement products was developed on linear ion trap/quadrupole MS. All components were monitored under time-scheduled multiple reaction monitoring (MRM) mode. The proposed method was further applied for investigating of 52 illegally manufactured sexual performance enhancementproducts sold in South Korea, and sildenafil and tadalafil together with their analogues were predominantly detected [15] . In 2014, Lebel et al. published a sensitive method for analysis of 71 synthetic and 11 natural erectile dysfunction ingredients, based on liquid chromatography coupled with high resolution orbitrap MS. The method was successfully applied to 32 samples, and among the 82 compounds, sildenafil, tadalafil, vardenafil and icariin were the four most common found adulterants [2] . An interesting approach how to screen and confirm the targeted and non-targeted PDE-5 inhibitors and their analogues by combination of UV and MS detection was described by Bartoliny et al. The diode array detector connected with quadrupole-time-of-flight (DAD-QTOF) system was used. The method was validated for seven standard analytes, namely yohimbine, sildenafil, vardenafil, tadalafil, homosildenafil, pseudovardenafil and hydroxyhomovardenafil. Among the 26 samples of dietary supplements, three samples were found to be contaminated with both registered and unregistered synthetic PDE-5 inhibitors, i.e. yohimbine, sildenafil, dimethylsildenafil and thiodimethylsildenafil / thiomethisosildenafil [16] . The latest study published by Vaclavik et al., validated according to AOAC Standard Method Performance Requirements, allowed to determine 54 PDE-5 inhibitors in botanical powders, extracts tablets and capsules.
Extraction by acetonitrile/water (50:50, v/v), followed by liquid chromatography separation with Q-orbitrap detection, was realized [17] .
The main goal of our study was to develop and validate a method based on ultra-performance liquid chromatography coupled with high resolution tandem mass spectrometry (U-HPLC-HRMS/MS) for identification and quantification of 59 compounds comprising PDE-5 inhibitors and their analogues, and employ it for analysis of 64 natural herbal-based preparations for erectile dysfunction treatment, which are available at the Czech market.
The other goal of this study aimed at proving the fraud associated with discrepancies in herbs composition declared by producers at products labels. In such cases, situations are even more difficult, and a 'tailor made' method dependent on the particular subject have to be developed. Alike in other cases of proving the adulteration [18, 19] , a U-HPLC-HRMS non-target fingerprinting was examined as a challenging and promising approach. Because development and application of such method, including building of a database of U-HPLC-HRMS records of authentic herb samples, is an extensive task deserving effort of separate study, we provide only an appetizing example, how to exploit the fingerprints acquired by Q-orbitrap full spectral MS method for retrospective mining of specific markers, and thereby to proof the presence or absence of the particular herb.
Materials and methods

Chemicals and reagents
The reference standards of sildenafil, tadalafil, vardenafil and their analougues, together with natural PDE-5 inhibitors icariin and yohimbine (purity ≥95%) were purchased from Toronto Research Chemicals (Toronto, Canada), Cachesyn (Mississagua, Canada), TLC Pharmachem (Vaughan, Canada), and Sigma-Aldrich (St. Louis, MO). The list of all 59 analytical standards is shown in the Table  S1 of Supplementary material. Acetonitrile was of HPLC grade and obtained from Sigma Aldrich (USA). Other reagents and chemicals were of analytical grade. Formic acid and ammonium formate were supplied by Sigma Aldrich (USA). Pure water for U-HPLC analysis was purified using a Milli-Q water purification system (Millipore, Germany) and was used for all solutions and dilutions.
Analyzed samples
Altogether, 64 samples of herbal-based dietary supplements intended for support of erection were purchased from the Czech market between 2009 and 2015. The samples were collected in cooperation with Czech Agriculture and Food Inspection Authority (CAFIA) as a part of regular control activity. All of the samples were declared as purely natural, containing extracts of herbs having beneficial influence on male erection (e.g. Panax ginseng, Gingko biloba, Epimedium alpinum, Tribulus terrestris, Capsicum annuum, Cordyceps sinensis, etc.). Twenty five samples were packed as capsules, and 39 samples as tablets. The composition of samples which were positive on PDE-5 inhibitors and/or their analogues is specified in Table  S2 of Supplementary materials.
For evaluation of matrix effects, a model sample with representative composition of herbs was selected. Its specification as given by the manufacturer was following: L-arginine, L-citruline, Tribulus terrestris, vitamin E, Ginkgo biloba, Schisandra chinensis, Crocus sativus, vitamin B3, lycopene, zinc (zinc oxide), luteine, folic acid, selenium (sodium selenite), vitamin B12. 
Samples and standards preparation
A homogenous sample was prepared by mixing the content of 10 capsules (poured out of the shells) or by grinding of 10 tablets to a fine powder. Then, 100 mg of homogenous sample was accurately weighted into the 15 ml centrifuge tube and extracted with 5 ml of acetonitrile/water (1:1, v/v) by sonicating for 15 min and then intensively shaked for 2 minutes. After extraction, the tube was centrifuged at 10,000 RPM for 5 minutes and then micro-filtrated (2 min, 5,000 RPM) before the U-HPLC-HRMS/MS analysis The mixed stock solution of analytical standards was prepared at concentration of 2 g/mL in acetonitrile and stored in the refrigerator. Working solvent standards were prepared by taking appropriate amount of mixed stock solution into vials, evaporating the solvent by gentle nitrogen stream, and filling by 1 mL of acetonitrile:water (1/1, v/v). The particular calibration points were 500, 200, 100, 50, 20, 10, 5, 2, 1, 0.5 ng/mL The matrix matched standards of the same concentrations were prepared by the same way, but the vials with dried standards were filled by the extract of model sample defined in the previous chapter.
Ultra high-performance liquid chromatography (U-HPLC)
U-HPLC was performed by using the UltiMate ® 3000 RSLC (Thermo Scientific, USA), equipped with a binary solvent delivery system and an autosampler with Kinetex ® C18 (100 × 2.1 mm; 2.6 m), (Phenomenex, USA) column. Mobile phase was composed of solvent A (0.2% formic acid with 5 mM ammonium formate in water) and solvent B (acetonitrile) with a gradient elution: 0 − 11 min, 25 − 100% B; 11 − 13 min, 100% B; 13.1 − 15 min, 25% B. The flow rate of the mobile phase was 0.3 mL/min, the column temperature was maintained at 40 • C and injection volume was 4 l.
High resolution tandem mass spectrometry (HRMS/MS)
For the determination of target analytes, high resolution tandem mass spectrometer Q-Exactive Plus TM (Thermo Scientific, USA) equipped with a heated electrospray interface was used. Mass spectrometer was operated in the full MS/data dependent MS/MS mode (full MS-dd-MS/MS). Full spectral information served for identification and quantification and MS/MS data for confirmation. An inclusion list of all target analytes carrying conditions regarding their fragmentation was implemented into the instrumental method (target analytes names, exact m/z values of precursor ions, and retention times). The mass spectrometer operated in positive mode and the interface parameters were as follows: spray voltage of 3.5 kV, capillary temperature of 350 • C, sheath gas flow of 30 arbitrary units, auxiliary gas flow of 7 arbitary units, S-lens RF level of 60 and, auxiliary gas heater temperature of 350 • C. In the full MS mode were used following parameters: scan range 200-1100 m/z, resolution 70,000 FWHM (defined for m/z 200; 3 Hz), automatic gain control (AGC) target 1e5, maximum inject time 20 ms, and in the dd-MS/MS mode: intensity threshold 1e4, resolution 17,500 FWHM (defined for m/z 200; 12 Hz), AGC target 1e5, maximum IT 50 ms, isolation window 1 m/z, and dynamic exclusion of fragmented analyte for 5 s. The collision energy in units of % normalized collision energy (NCE) was experimentally set for each analyte.
The external mass calibration of the Q-Exactive Plus instrument in ESI + was performed prior to every measurement. The orbitrap instruments tend to generate rather high mass errors ( m/z >10 ppm) for low molecular weight ions close to m/z 50 (typically the fragment ions). For data evaluation, XcaliburTM 3.0 and TraceFinderTM 3.2 (both Thermo Scientific, San Jose, CA, USA) were used.
Method validation
Before the U-HPLC-HRMS/MS method was used for analysis of real samples, proper validation was conducted. To evaluate linearity, calibration curves were constructed by plotting the peak areas of the standard compounds against the corresponding concentrations. Because in food supplements preparations, analytes could be present in unpredictable concentrations, calibration range should be as broad, as possible. Calibration batches from 0.5 to 500 ng/mL (i.e. 0.025 to 50 g/g) were prepared. The limits of quantification (LOQs) were determined as the lowest concentration levels of matrix-matched calibration batch, providing a stable signal in four consecutive days. In order to determine method repeatability, which was calculated as a relative standard deviation (RSD) of spikes in six repetitions, spiked samples were prepared at two concentration levels 0.25 and 5 g/g (for this purpose, the model sample characterized in section 2.3 was used. Recoveries were determined by using of these spikes at both concentrations and the matrix matched standards.
The matrix effects expressing the matrix induced signal suppression/enhancement (SSE%) were defined as percentage ratios of matrix-matched calibration standard to solvent standard at a concentration of 5 ng/mL. All the validation parameters for all of the analytes are summarized in Table S4 of Supplementary material.
Quantification of analytes in real samples
In the first step of samples analysis, the presence of PDE-5 inhibitors was screened in undiluted samples extracts. In the second step, the positive samples were selected and diluted 10x, 100x and 1000x into acetonitril/water (1:1, v/v), and analysed again. For quantification, the most convenient dilution matching the linear range of MS detector was considered. For quantification of analytes, the calibration batch of solvent standards was used.
Results and discussion
Within the development of the sensitive method for analysis of 59 PDE-5 inhibitors, both sample preparation procedure, as well as separation / detection conditions have been optimized. Extraction efficiency of particular extraction solvents, influence of different mobile phase additives on target analytes separation, as well as impact of various settings of mass analyzer on sensitivity of detection were examined, and are deeply discussed in following sub-chapters.
Optimization of extraction
Within the optimization of extraction, five different extraction solvents (acetonitrile, methanol, acetonitrile : water, 50:50 (v/v), methanol : water, 50:50 (v/v), and methanol : water, 70:30 (v/v)) previously used in similar studies were tested [3, [20] [21] [22] [23] .
The extraction experiments were realized by using the real-life samples, i.e. samples in which presence of the 'incurred' analytes was proved by a preliminary screening. The samples No 5 and 6 (Table S2 of Supplementary material) were mixed up in order to gain a matrix with as broad range of incurred analytes as possible (sildenafil, tadalafil, sildenafil-N-oxide, propoxyphenylsildenafil, N-desmethylsildenafil, chloropretadalafil, icariin, imidazosagatriazinone, and nitrodenafil were present). As demonstrated previously on different groups of analytes and matrices (e.g. pesticides or mycotoxins in food [24, 25] , optimization of extraction by using real-life samples is considerably more realistic than using the spikes, where the recovery results can be biased by weaker bonds of analytes to the matrix. As can be seen from Fig. 1 , when comparing amounts of analytes isolated from dietary supplement samples, the best extraction efficiency showed acetonitrile : water, 50:50 (v/v); it should be noticed that before injecting into the U-HPLC-HRMS/MS system, all extracts were firstly 10-times diluted into the mobile phase (75% of 0.2% formic acid with 5 mM ammonium formate in water and 25% acetonitrile) to prevent misinterpretation of results caused by solvent induced ionization suppression / enhancement. During the experiments, effect of prolonged time of sonication and prolonged time of extraction on analytes recovery was also tested, nevertheless, no statistically significant differences in determined concentrations were noticed.
U-HPLC-HRMS method development and optimization
Liquid chromatography
Because some of the PDE-5 inhibitors are isomeric compounds, they cannot be resolved on the basis of exact mass measurement. That is why for, sufficient chromatographic separation is critical for their reliable identification. Due to multiple basic nitrogen groups contained in molecules of these compounds, they are extremely sensitive to pH of mobile phase used. Non-optimal peak shape, including peaks tailing, is often associated with the presence of analytes in both neutral and ionized forms. In our study, we aimed to minimize and eliminate these problems by examining different concentrations of formic acid (0, 0.1, 0.2%) and ammonium formate (5, 10, 20 mM) in aqueous mobile phase. As resulted from the obtained chromatograms, considerably better separation of analytes isomers was achieved when the formic acid was present. In particular, concentration of 0.2% of formic acid in the aqueous mobile phase showed significantly better separation of critical triplets of acetildenafil, dimethylacetildenafil, acetylvardenafil (m/z 467.2765), and propoxyphenylthiosildenafil, thioaildenafil and thiohomosildenafil (m/z 505.2050), than the nonacidified mobile phase (see Fig. 2 ).
With respect to the concentrations of ammonium formate, the highest peak intensities were obtained when the mobile phase with the lowest concentration of this additive (5 mM) was used. With increasing concentration of buffer, peak signal intensities of analytes gradually decreased (to approx. 50% in 10 mM, and to approx. 10% in 20 mM ammonium formate). As we found out, our observation was in accordance with the literature; as published in other studies, ammonium formate increases the ionic strength of mobile phase, which results in discharges and poor spray performance of the ESI interface [10, 26, 27] .
Aside from the mobile phase composition, the gradient was shown to have a significant impact on isomeric compounds separation. Fig. 3 clearly shows the influence of the amount of acetonitrile (as a strong component of the mobile phase) on acetildenafil, dimethylacetildenafil, and acetylvardenafil separation. The separation of optimized method was realized in 15 min, unlike majority of the other published methods [14, 16, 17] (Table 1) requiring two up to three times longer separation time.
Mass spectrometry
In order to assure the best ionization and detection conditions, particular attention was paid to proper settings optimization of different parameters of Q-Exactive, quadrupole-orbitrap mass spectrometer (starting with tuning of ion source conditions, over the specific settings of ion optics, to modifying of conditions in the C-trap, orbitrap, and collision cell). Optimization experiments were realized by the introduction of standard mixture in acetonitrile into the ion source. In comparison with other studies this is the first study discussing such deep details of Q-orbitrap analyser / detector settings, resulting in significant improvement of detection sensitivity [2, 17] .
Selection of ionization mode and most abundant ions suitable for detection
In the first step of the method development, the ionization mode of ESI detection (ESI + or ESI-) was chosen. It was found that majority of analytes (85%) shows higher ion intensities in ESI + as pseudo- With the aim to simplify the method as much as possible (i.e. avoid polarity switching, which could be demanding together with simultaneous fragmentation), we decided to use the ESI + only. Moreover, analytes in the samples were not expected to be present at trace levels, so obtaining of extra-low LOQs was not necessary. List of compounds and their characteristic ions are shown in Table S3 of Supplementary material.
Optimization of ionization conditions
In order to achieve the most effective ionization of analytes as possible, proper gasification of the mobile phase entering the ion source, and ensuring effective ionization, is necessary. That is why parameter tuning in the ion source was first of all focused on optimization of (i) flow rates of nitrogen gas line (sheath gas and auxiliary gas), (ii) temperature of the ESI probe, (iii) ESI capillary voltage, (iv) temperature of the ion transfer capillary, and (v) Slens level. Both nitrogen gas lines help to focus the stream of mobile phase with analytes coming from the capillary tip towards the mass spectrometer, and optimization with respect to the mobile phase flow rate is necessary for complete gasification and effective ionization in the ion source. Also optimization of the temperature of the ESI probe and ion transfer capillary is important for the same reason As concerns the ESI capillary voltage, the non-optimal (too high) values could cause the unwanted side reactions leading to ion source discharges, thus decreasing detection sensitivity. The Slens RF level is a dimensionless value related to capturing the ions, their focusing and transferring through the capillary, and is also important for good method sensitivity. As we found out, modifying of the default setting values recommended by instrument producers significantly improved detection abilities of Q-Exactive mass analyzer to a high extent. The optimal values are summarized in Table 2 . As regards the sheath gas flow rate and ESI capillary voltage, the default values were finally decided as the optimal ones, because the improvement of ionization efficiencies was rather negligible and was observed only for approximately 17% of analytes. As concerns the other tuned parameters, improvements in the intensities, as compared with the default values settings, were as follows: new setting of auxiliary gas flow rate improved the detectability for approximately 15% of analytes with 10-50% improvement, new settings of ESI probe temperature helped to increase the ion intensities for 39% of analytes up to 31%. Changing the temperature of ion transfer capillary helped to improve ionization of 18% analytes by up to 51% and changing the S-lense RF level positively influenced intensities of all of the analytes by up 80%.
Optimization of detection conditions
The detection of 59 PDE-5 inhibitors was realized by employing the Q-orbitrap mass analyzer working in the high resolution mode (i.e. 75,000 FWHM at 200 m/z). When separating the ions in the mass analyzer, two main parameters influencing the number of ions in orbitrap are the most relevant -the (i) maximum inject time, and (ii) automatic gain control). Maximum injection time is the maximum time for which the ions can be held in the curved linear ion trap (C-trap) before entering the orbitrap. The default value of 20 ms was considered to be suitable for the majority of the analytes. As concerns the automatic gain control, referring to the maximum amount of ions in C-trap before entering the orbitrap, most of analytes showed the highest intensities for the value 2e4.
However, at the same time, some analytes with worse sensitivity of detection were not detected under these conditions. That is why the value of 1e5 was used in the final method setting.
Optimization of fragmentation
After optimization of the ionization and detection conditions, the attention was concentrated for tuning the ions fragmentation, because the availability of MS/MS data are crucial for reliable screening and identity confirmation of all target analytes. The MS/MS spectra were recorded in the data-dependent product ion scan mode through the isolation and fragmentation of their respective pseudomolecular ions. The normalized collision energy (NCE, %) was tested on nineteen levels (from 10 to 100%), and then the most abundant fragment ions were selected. The obtained complex of MS/MS records in high resolution (MS/MS library) was exploited as another confirmation criterion for compounds identification, and is a unique outcome of this study (it should be noticed that the HRMS/MS library created is easily transferable between different Q-orbitrap instruments, which could be very practical for extending the method applicability). The overview of exact masses of most important fragments (calculated retrospectively from the measured masses of fragment ions), together with the optimal NCE values, is summarized in Table 3 . Several product ions frequently occurring in records of parent PDE-5 inhibitors and their analogues was possible to better characterize by using the scientific literature. For example, m/z 58.0651, 99.0917, and 283.119 were typical for sildenafil and its analogues. Fragment ion with exact mass m/z 58.0651 results from cleavage of the methyl piperazine ring and cleavage of the S-N bond between the piperazine ring and the sulfonyl group [28] , m/z 99.0917 is attributed to piperazine moiety, and m/z 283.119 results from the cleavage of the C-S bond and loss of the ethyl group on the ethoxy substituent on the phenyl ring. Further, fragment ion m/z 135.0441 was characteristic for tadalafil and its analogues, and fragment ions m/z 169.0972 (corresponding to pyridine-indole ring) and 344.1479 were characteristic for vardenafil and its analogues [15] .
Validation of the method
The linearity of each of the 59 PDE-5 inhibitors was estimated in the concentration range of 1-500 ng/mL. Linear regression was obtained by plotting the peak area responses of each compound as a function of its respective concentration. Regression coefficients (R2) ranged from 0.9992 to 1.0000. As concerns the LOQs, they were 0.025 g/g for 90% of analytes, and 0.25 g/g for 10% of analytes, which was considered as satisfactory for very sensitive detection of target analytes. The obtained LOQs in the range 2-40 pg per injection are lower or comparable with other published methods (Table 1 ). The mean recoveries ranged from 77 to 101% (at spiking level 5 g/g), and 72 to 95% (at spiking level 0.25 g/g), and complied the requirements on the performance characteristics of analytical methods stated by SANTE/11945/2015 (guidance document describing the method validation and analytical quality control requirements in pesticides residues analysis, but generally applicable for analysis of any food contaminants). The method had also good repeatability with RSD values of 2.1-4.2% at spiking level 5 g/g, and 2.8-5.2% at spiking level 0.25 g/g, sufficiently below the repeatability criteria of ≤20% layed down by SANTE/11945/2015. As concerns the matrix effects, the SSE values lied in the range 100-75%, illustrating a very minimal matrix induced ionization suppression. Nevertheless, when analysing the real-life samples, where the PDE-5 inhibitors usually occur at concentrations of g/g up to mg/g, the dilution of samples necessary for matching the linear range of the detector minimizes the matrix influence even more, thus quantification on neat solvent standards is enabled. All the validation parameters for all of the analytes are summarized in Table S4 of Supplementary material.
Analysis of real samples
The developed U-HPLC-HRMS/MS method optimized for analysis of 59 various PDE-5 inhibitors was employed for screening and quantitation of these analytes in 64 samples of dietary supplement preparations declared as purely 'natural' erectile supporters. The samples were continuously collected by the CAFIA during 2009 and 2015 as a part of official control activities, and stored in a deposit freezer until analysis. The ultra-high resolution of Q-orbitrap mass analyzer enabled measurement of targeted ions with very high mass accuracy, when the mass detecting error usually does not exceed 2 ppm. This advantage assures the method selectivity by filtering out the ions of co-eluting matrix compounds with very similar masses, thus avoiding the false positive results. Because miss-interpretation and accusation the producer of illegal addition of PDE-5 inhibitors could have serious economic consequences, the method should pose as many confirmatory criterions as possible. This is especially true when analyzing samples containing very complex matrix, mixture of herb extracts in this particular case. As a powerful confirmatory criterion, pattern of fragment ions acquired during the parallel MS/MS experiment was used. Assessment of the compliance of fragmentation spectra of suspicious analyte with an 'in-house created' MS/MS library (i.e. library of fragmentation patterns of standards of PDE-5 inhibitors being built within the method development) was realized. Processing of quite extended data set (64 samples and 59 analytes) was performed by the TraceFinder 3.2 software, and included automatic evaluation of following criteria: (i) minimum peak area threshold 5e 4 (ii) conformity of retention times as a maximum deviation between expected and experimentally measured retention time was set to 0.1 min, (iii) calculated mass detecting error of the precursor ion in full MS (max m/z) was set to 5 ppm, (iv) conformity of isotopic patterns as a maximum deviation between the theoretical and experimental isotopic pattern comparison was set to m/z 5 ppm in maximum, and 10% of the intensity deviation, (v) presence of diagnostic fragment MS/MS ions, and (v) agreement of the entire MS/MS fragment ions pattern with the MS/MS library (match threshold was 50%).
For quantification of analytes, calibration batch of solvent standards was used. With regard to the high concentration of PDE-5 inhibitors in the samples, and necessity to dilute the extract up to 10 000-times, the matrix effects were eliminated, and quantification on solvent standards did not cause any bias. As illustrated in Fig. 4 , from the 64 samples analyzed, 10 samples was revealed to be positive for at least four up to ten analytes. Five of these 10 adulterated samples originated from China, three of them came from Canada, one from Great Britain and in one case, the country of origin was not declared. The highest number of PDE-5 inhibitors was present in samples No 3 and 9 originated from China.
Altogether, 20 different analytes were identified in these samples. Between the most frequent PDE-5 inhibitors belonged sildenafil, imidazosagatriazinone, sildenafil-N-oxide, and propoxyphenylsildenafil. These three later named sildenafil analogues occurred in 1,000-times up to 10,000-times lower concentrations than the original sildenafil (which was present mostly in tens thousands up to hundreds thousands g/g). Considering these 'trace' concentrations of the analogues, we can speculate that they are most likely by-products of parent sildenafil production, which indicates that for adulteration purposes, synthetic products of undefined chemical purity are used (which in fact even increase the consumers risk, because these substances have not been clinically tested and information about contraindications and side effects are lacking). In one sample (sample No 9), sildenafil analog noracetildenafil was revealed to be the main one (at concentration 222,445 g/g), without the presence of original sildenafil. This probably means that the producer wanted to 'mask' the presence of synthetic PDE-5 inhibitor by addition of a less traditional compound. Also a different spectrum of minor by-products (in particular gendenafil, hydroxyhomosildenafil, hydroxythiohomosildenafil, imidazosagatriazinone, and thioaildenafil) was present in this sample. In the other sample (No 5), approximately the same concentrations of sildenafil and tadalafil were found (in particular 19,700 and 35,500 g/g, respectively), indicating that producer probably used both active ingredients intentionally to support the biological effect in maximum extent. In two of 10 samples (No 3 and 4), tadalafil was identified as the major illegal PDE-5 inhibitor. In the first one (No 3) containing 3,970 g/g of tadalafil, also relatively high concentrations of sildenafil (404 g/g) and icariin (730 g/g), the naturally produced secondary metabolite of Horny Goat Weed (Epimedium sp.) plant, were found. The second 'tadalafil-based' sample (No 4) contained 418,000 g/g of tadalafil, and trace amounts of its by-products N-desmethyltadalafil, chloropretadalafil and aminotadalafil. The trace amounts of natural PDE-5 inhibitor icariin were present in two samples (No 6 and 9) at levels 4.41 and 6.97 g/g, respectively. In all three samples in which icariin occurred, the Epimedium sp. was declared as an ingredient (as is stated in Table S1 of Supplementary material). The concentrations of all Table 3 Identified MS/MS fragments (fragments are listed with their decreased intensity). Black highlighted -100-50% of the intensity of the most intense ion. Red highlighted -less than 50% of the intensity of the most intense ion. Blue highlighted -less than 10% intensity to the most intense ion. * The most intensive ion.
Table 4
The content of PDE5 inhibitors and their analogues in herbal supplements expressed as g/g. identified PDE-5 inhibitors in positive samples are summarized in Table 4 .
According to the information present in Viagra ® leaflet, the recommended daily dosage of sildenafil is 50 mg, with a possibility to take an increased dosage of 100 mg or lowered dosage of 25 mg, in dependence on the personal health (the lowered dosage is usually recommended to people with kidney or liver diseases). As regards samples analyzed in our study, amount of 50 mg of sildenafil per one capsule or tablet was exceeded in four cases, and amount of 25 mg per one capsule was exceeded in five cases. As concerns tadalafil, active substance of Cialis ® , the maximum dosage recommended by producer (10 mg) was exceeded in both samples which were adulterated by this compound (in sample No 4 even 10-times).
The results of total content of sildenafil and tadalafil per dosage (in mg/capsule or tablet) are summarized in Table 5 .
Utilization of U-HPLC-RMS/MS fingerprints for control of trueness of dietary supplements composition
The following paragraph demonstrates how the U-HPLC-HRMS/MS fingerprints can be used for non-target screening and proving evidence about the presence / absence of particular herb extract declared on the product packaging.
In some samples of analyzed dietary supplements, natural PDE-5 inhibitor icariin (presence of which is not restricted) was found. This compound is known to be naturally present in Epimedium sp. plant (sometimes called Horny Goat Weed), and thereby can be indicative for presence of the Epimedium sp. in the products. When considering the fact that icariin in Epimedium sp. usually occurs at levels 3,000 -16,300 g/g [29] , the plant addition of 0.0002 -0.0008 % should be detectable. In spite of the fact, that Epimedium sp. was declared in four samples, icariin was detected in only three of them. We found out that this marker compound was completely missing in sample No 1 originated from China, so the U-HPLC-HRMS/MS fingerprint of this sample was subjected to further investigation. To our surprise, neither the presence of markers of the other plants declared on the packaging, Tribulus terrsestris and Panax ginseng, could be confirmed (list of saponins as main erectile supporters of Tribulus terrestris, and ginsenosides of Panax ginseng, which were searched for in the sample, are summarized in Table 6 ). It is worth to emphasize that in this sample, sildenafil was detected as major PDE-5 inhibitor at concentration 1,980 g/g, together with its four analogues sildenafil-N-oxide (111 g/g), N-desmethylsildenafil (12.5 g/g), propoxyphenylsildenafil (0.62 g/g), and imidazosagatriazinone (0.62 g/g). The presence of synthetic PDE-5 inhibitors, together with absence of markers of the herbs declared provided the irrefutable proof of the fraudulent practices of supplement manufacturer.
Within our future research, we will aim to build the own representative databases of herbs usually used for dietary supplements production, and by using the metabolomics fingerprinting strategy, to identify the other markers which could be diagnostic for proof of presence of particular herbal plants (the data from acquired U-HPLC-HRMS fingerprints will be processed and evaluated by the advanced tools of multivariate analysis, according to the concept previously described in the other studies of authors' research group [30, 31]
Conclusions
The research described in this paper was focused on development and validation of a method for targeted screening, identity confirmation and quantification of 59 PDE-5 inhibitors and their analogues in 64 natural herbal-based preparations for erectile dysfunction available at the Czech market. Between the main novel aspects of the method, its high throughput could be named. The optimized separation was realized in 15 min. Optimization of extraction procedure was realized on real-life samples containing incurred analytes, and as the best extraction solvent, acetonitrile:water (50:50, v/v) was selected. As resulted from the optimization of chromatographic separation, 5 mM ammonium formate and 0.2% formic acid were the best additives for both water and acetonitrile mobile phases. As concerns the MS detection, a unique library of fragmentation mass spectra in high resolution, easily transferable to the other Q-orbitrap instruments, was built in the study, and its utilization within the analytes confirmation was demonstrated. The validation parameters of this method, such as linearities, regression coefficients, LOQs, recoveries and matrix effects were acceptable and complied the requirements on the performance characteristics of analytical methods stated by SANTE/11945/2015.
The optimized method was successfully applied for the analysis of real samples, and from the 64 samples purchased at the Czech market, 10 samples were revealed to be positive for non-declared PDE-5 inhibitors. Sildenafil and tadalafil were usually detected as the major active compounds (at concentrations of hundreds of mg/g), and their analogues occurred at 1,000-up to 10,000-times lower levels. In one case, the sildenafil analogue noracetildenafil was present at concentration typical for the major compound (hundreds of mg/g), which points to the probable effort of manufacturer to mask the usage of synthetic PDE-5 inhibitors. Beside this, a potential of retrospective assessment of the acquired fingerprints to reveal frauds in dietary supplements composition was demonstrated. Absence of herbs declared on the product packaging was revealed in one sample by retrospective investigation of marker compounds in U-HPLC-HRMS/MS fingerprints.
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